Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 05-Sep-24
Select bar for recommendation details.
Recommendations | 05-Sep-24 | |
---|---|---|
Buy | 3 | |
Outperform | 4 | |
Hold | 5 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 11 analysts offering 12 month price targets for Hikma Pharmaceuticals Plc have a median target of 2,333.43, with a high estimate of 2,872.21 and a low estimate of 1,994.23. The median estimate represents a 19.30% increase from the last price of 1,956.00.
High | 46.8% | 2,872.21 |
Med | 19.3% | 2,333.43 |
Low | 2.0% | 1,994.23 |
Dividends in USD
Div growth (TTM) | 30.11% |
---|
More ▼
Earnings history & estimates in USD
Average growth rate | +10.73% |
More ▼
Revenue history & estimates in USD
Average growth rate | +6.99% |
More ▼